Details
Re-evaluation decision RVD2023-17, 1,3-bis(hydroxymethyl)-5,5-dimethylhydantoin and hydroxymethyl-5,5-dimethylhydantoin and its associated end-use products - Canada.ca
Metadata and links for an archived snapshot.
- Source
- Health Canada
- Date
- Jan 4, 2026 · edition #6
- Timestamp
- 2026-01-04T19:22:59.803Z
- Language
- en
- ID
- 461073
- Status
- 200
- Type
- text/html
Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.
Other snapshots
Jan 4, 2026 · (this snapshot)
hc-20260101
Apr 19, 2025
legacy-hc-2025-04-21
Apr 19, 2025
legacy-hc-2025-04-21
Apr 18, 2025
legacy-hc-2025-04-21
